Seoul Asan Hospital
Seoul Asan Hospital
Seoul, South Korea2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SB17170 Phase 2 Trial in IPF Patients | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Phase 2 | 2025-11-19 | NCT06747923 | |
| Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer | Non Squamous Non Small Cell Lung Cancer | Recruiting | Phase 2 | 2023-08-30 | NCT05841472 |